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doi:10.1016/j.ejvs.2011.06.053Abstract Objectives: Surveillance after Endovascular Aneurysm Repair (EVAR) is considered
mandatory, but the optimal regimen remains controversial. The aim of the present study was
to report the nature of routine post-EVAR surveillance protocols in the UK, in order to identify
thedegreeof variation in national practiceand from themanufacturer’s instructions foruse (IFU).
Methods: A telephone surveywas administered to 41 centreswith 10 years’ experience in EVAR to
identify their standard surveillance protocol after EVAR. Data were collected regarding the
number of surveillance CT or ultrasound performed up to 5 years postoperatively.
Results: 12/41 centres usedCTas theprimarymodeof surveillance, 14/41 centres usedUSS as the
primary mode of surveillance, and 15/41 centres used a combination of CT and USS. The
mean  s.d. number of CT scans performed cumulatively up to 1 year and 5 years post surgery
were 1.1 0.6 and 3.5 2.9 respectively. Themean s.d. ultrasound scans performed at 1 year
and 5 years post surgery were 0.5  0.9and 4.7  3.6 respectively.
Conclusions: Significant heterogeneity exists in surveillance after EVAR in the UK. Efforts should
be made to establish consensus towards a national surveillance protocol.
Crown Copyright ª 2011 Published by Elsevier Ltd on behalf of European Society for Vascular
Surgery. All rights reserved.Introduction
Endovascular repair (EVAR) of abdominal aortic aneurysms
(AAA) has been shown to reduce peri-operative mortality. George’s Vascular Institute,
NHS Trust, Blackshaw Road,
0 8725 3205; fax: þ44 (0)20
P.J.E. Holt).
11 Published by Elsevier Ltd on becompared to open repair, but is associated with a higher
rate of subsequent reintervention and aortic rupture.1,2
Long-term follow-up data from randomised controlled
trials (RCTs) suggest that a significant rate of graft-related
complications persists up to 8 years after EVAR.3,4 These
findings are consistent with a pooled survival analysis of
over 10,000 patients, which reported reintervention-free
survival in 81.5% of cases after 5 years, with a linear
requirement for reintervention.5 Lifelong post-operative
surveillance is therefore considered mandatory to identify
graft-related complications and to direct reintervention.half of European Society for Vascular Surgery. All rights reserved.
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from those outlined in RCTs or early registries, which used
contrast-enhanced Computed Tomography (CT) as the gold
standard of surveillance.1 However, excessive reliance on
CT is expensive6 and necessitates the repeated exposure of
asymptomatic patients to nephrotoxic intravenous
contrast7 and ionising radiation.8 Increasing the propor-
tional use of non-nephrotoxic imaging modalities after
EVAR has been subsequently advocated as an alternative
strategy to reduce surveillance-related morbidity.9 An
increased reliance on duplex ultrasound appears a safe
strategy in selected patients, and offers reasonable accu-
racy compared to CT for endoleak detection.10e12
The modality, timing and overall necessity of surveil-
lance remain controversial11 and surveillance accounts for
a significant proportion of the long-term excess cost of
EVAR compared to open repair.13 In light of changing trends
for post-EVAR surveillance and improvements in the design
of endovascular stent-grafts, there is a need for a contem-
porary appraisal of surveillance after EVAR in the UK. The
aim of the present study was to report the nature of routine
post-EVAR surveillance protocols in current use throughout
the UK, in order to identify the degree of variation in
national practice and the degree of variation from the
manufacturer’s instructions for use (IFU).Methods
To interrogate variation in national practice and to limit the
potential confounding effect of technical inexperience,
a list of centres with at least 10 years’ experience in EVAR
in the UK was desired. The inclusion criteria of this study
were therefore limited to 41 centres that had been enrolled
in the EVAR-1 trial.1
Representatives from each centre were contacted and
a standardised clinical scenario was administered by tele-
phone and email. The survey was conducted during a 3-
month period starting in June 2010. Responses were
obtained from both a consultant vascular surgeon and an
associated healthcare professional (junior surgeon, sonog-
rapher or specialist nurse) at each centre, and a consensus
opinion for each response was required and obtained for
inclusion in the study. Differences in opinion were resolved
through the representative consultant in each centre. In
order to minimise variation in respondents’ approaches to
patient preference, operative complexity and types of
endograft, a standard clinical scenario was chosen and
presented to survey respondents as follows: “Questions
relate to a 65-year old healthy male infrarenal EVAR
patient with no co-morbidities. He lives near to the
hospital, is independent and has no objections to surveil-
lance. The operation was successful with no complications.
He had a Cook Zenith stent-graft placed within the
manufacturer’s indications for use (IFU)(Cook Medical,
Bloomington, Indiana, USA). Technical success and Clinical
Success were achieved as per consensus definitions.14 What
is your routine surveillance imaging protocol in this
patient?”
To minimise bias, data were collected and stored by two
non-specialist junior doctors (AAP, CP) using a standardised
web-hosted proforma constructed using Filemaker Prosoftware, version 10 (Filemaker Inc., Santa Clara, CA, USA).
Respondents were specifically interrogated to obtain data
regarding the number of CT, ultrasound (USS), plain
abdominal radiography, or angiographic examinations per-
formed at set post-operative timepoints: at discharge from
hospital, 6 weeks, 3 months, 1 year, 3 years and 5 years
postoperatively. Descriptive analysis of survey responses
was performed using SPSS software, version 16.0 (SPSS Inc.,
Chicago Ill, USA). No funding was received for this study and
no device manufacturers were involved in the study.
Results
All 41 EVAR-1 centres participated and the response rate
was complete at 100%. Concordant responses were
obtained from 2 representatives at all 41 UK EVAR-1
centres. 12/41 centres used CT as the primary mode of
surveillance, 14/41 centres used USS as the primary mode
of surveillance, and 15/41 centres used a combination of CT
and USS.
Imaging prior to discharge from hospital
All 41 centres performed completion angiography at the
end of EVAR. 18/41 (43.9%) performed 1-view angiography,
21/41 (51.2%) performed 2-view angiography and 2/41
(4.9%) performed rotational CT-angiography. 12/41 (29.3%)
performed CT prior to discharge, 6/41 (14.6%) performed
duplex USS prior to discharge and 5/41 (12.2%) performed
2-view plain abdominal radiography prior to discharge. 24/
41 centres performed neither CT nor duplex USS prior to
discharge and in these centres 1-view completion angiog-
raphy was performed in 11/24 (27%), 2-view completion
angiography in 11/24 (27%) and rotational CT angiography in
2/24 (8.3%).
Computed tomography for EVAR surveillance
The mean  s.d. number of CT scans performed at the point
of discharge and then cumulatively up to 6 weeks, 3
months, 1 year, 3 years and 5 years post surgery were
0  0.5, 0.9  0.5, 1.1  0.6, 2.1  1.2, 2.5  1.7, 2.8  2.0
and 3.5  2.9 (Fig. 1).
Duplex ultrasound for EVAR surveillance
The mean  s.d. Duplex Ultrasound scans performed at the
point of discharge and then cumulatively up to 6 weeks, 3
months, 1 year, 3 years and 5 years post surgery were
0  0.3, 0.4  0.7, 0.5  0.9, 1.5  1.7, 2.3  2.1, 3.1  2.6
and 4.7  3.6 (Fig. 2). Duplex was performed in all centres
by specialist vascular sonographers.
Plain abdominal radiography for EVAR surveillance
The mean  s.d. plain abdominal radiographs performed at
the point of discharge and then cumulatively up to 6 weeks,
3 months, 1 year, 3 years and 5 years were 0  0.3,
0.3  0.5, 0.3  0.5, 1.1  1.2, 1.8  1.7, 2.4  2.3 and
3.5  3.3 (Fig. 3). Plain abdominal radiography was
Figure 1 Cumulative use of Computed Tomography in EVAR Surveillance protocols currently employed by 41 UK EVAR-1 centres,
and compared to the surveillance protocol specified in the manufacturer’s Instructions For Use (IFU).
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integrity and assess for evidence of migration.
Removing patients from a postoperative
surveillance program
11/41 (27%) of centres would remove the patient from
surveillance after 5 years provided there was no evidence
of endoleak, stent-graft migration or other complication
requiring reintervention. 30/41 (73%) of centres would
continue surveillance indefinitely.
Compliance with manufacturer’s IFU
3/41 centres were fully compliant with the manufacturer’s
IFU for surveillance, which specified a CT scan should be
performed at discharge or within 1 month postoperatively
and subsequently at 3 months, 6 months and 12 months
postoperatively, and annually thereafter (Fig. 1).15 10/41
centres were non-compliant because they did not conduct
a CT scan within 1 month of the procedure (or at the time of
discharge). 25/41 centres conducted a CT within 1 month
but did not conduct a CT scan at 3 months post-procedure.
3/41 conducted CT scans within 1 month and at 3 months
but did not conduct a CT scan at 6 months postoperatively.
Discussion
The results of this survey demonstrated significant hetero-
geneity in the intensity and modality of post-operativeFigure 2 Cumulative use of Duplex Ultrasound in EVAR Surveillsurveillance protocols employed across the UK at centres
experienced in EVAR. The same patient undergoing infra-
renal EVAR in the UK, within the manufacturer’s IFU and
without the need for unexpected adjuncts, might receive
no CT scans in 5 years following the operation, or undergo
up to 10 CT scans in the same period, depending on which
hospital performed the operation. This discrepancy was
mirrored in the variation with which plain abdominal radi-
ography and duplex ultrasound were used nationally. Whilst
27% of centres advocated cessation of surveillance in
uncomplicated patients after 5 years, 73% of centres
reported continuation of surveillance beyond this period
and do not have a defined endpoint for surveillance. 3/41
(7.3%) of centres were compliant with the manufacturer’s
IFU, which specified intensive CT surveillance.
The heterogeneity seen in national practice reflects
ongoing uncertainty surrounding the nature of surveillance
that should be employed following EVAR. The long-term
persistence of graft-related complications requiring rein-
tervention justifies a continuing need for surveillance,5 yet
the most effective method for surveillance remains
unknown. In studies that have investigated the reasons
underlying post-EVAR reintervention, it has been reported
that 61e98% of re-interventions were initiated by the
unexpected symptomatic presentation of patients inde-
pendently of post-operative surveillance.16e18 These data
suggest that surveillance protocols provided no benefit in at
least 90% of patients as complications occur between
surveillance scans.16e18 It has also been reported that 15%
of post-EVAR aneurysm ruptures occur in patients with
no stent abnormality detected on post-operative imaging.19ance protocols currently employed by 41 UK EVAR-1 centres.
Figure 3 Cumulative use of plain abdominal radiographs in EVAR Surveillance protocols currently employed by 41 UK EVAR-1
centres.
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tion about variation in the clinical follow-up of patients
after EVAR, which is of importance alongside radiological
follow-up within the overall scheme of graft surveillance.
Generic graft surveillance regimens that are the existing
standard-of-care were derived from early multi-centre
trials that employed earlier generations of endograft
technology and were more heavily reliant on regular CT.1
The application of these data to present practice may
lack validity in the face of changing trends in post-opera-
tive surveillance. Furthermore, intensive use of CT as seen
in some centres (Fig. 1) may lead to cumulative renal injury
sustained due to the repeated administration of nephro-
toxic contrast agents.7,20,21 Cumulative Radiation exposure
is also of concern. An estimated dose of 13 mSv per scan has
previously been reported for CT in pre-operative EVAR
planning.8 Based on this estimate, a patient’s radiation
exposure in the present study varies from 13 mSv to
130 mSv during the first 5 years after EVAR in the UK.
However, estimating the risk of malignancy due to cumu-
lative abdominal CT is complex. The estimated lifetime
attributable risk of cancer following a single 10-msV
abdominal CT scan in a patient over 50 years old is small,
approximately 0.02%.22 Cumulative CT has a stochastic
effect on the risk of malignancy and although the proba-
bility of malignancy increases with each CT scan, its
severity is independent of the total radiation dose sus-
tained. Further variation is introduced by the effect of
patient age, gender and the CT protocol employed.”
It has been proposed that after one year CT can be
reserved for those patients in whom ultrasound identifies
growth or persistently unstable aneurysm diameter.23 Other
studies have suggested that in the presence of normal
imaging at one to three months, imaging at 6 months does
not identify any clinically significant findings warranting
intervention.24 Equally the efficacy of an early post-
procedural CT, performed in 12/41 centres in the present
study, has been questioned. It has been shown that this
scan fails to influence treatment in 99% of cases,25 yet
surveillance at this stage remains recommended in the
manufacturer’s IFU15 and long-term data from the EVAR
trials suggest it may prevent rupture by improving the
detection and treatment of remediable complications.26
The medico-legal consequences of national variation in
post-EVAR surveillance are of interest. Tests of medicalnegligence in English law often include consideration of
whether a doctor is in breach of “the practice of a respon-
sible body of medical opinion”. Reference to the practice
of a body of medical opinion in this manner is often termed
the “Bolam test”.27 The present study highlights significant
variation in practice amongst the specialist body of vascular
surgeons in the UK. It could therefore be suggested that
deviation from the Manufacturer’s surveillance guidelines
might have few medico-legal consequences according to
the “Bolam test”. However, the Bolam precedent has been
challenged in more recent cases. Most significantly the
judgement of the Bolitho case28 stated explicitly that “the
court has to be satisfied that the exponents of the body of
opinion relied upon can demonstrate that such opinion has
a logical basis. In particular, in cases involving, as they so
often do, the weighing of risks against benefits, the judge
before accepting a body of opinion as being responsible,
reasonable or respectable, will need to be satisfied that, in
forming their views, the experts have directed their minds
to the question of comparative risks and benefits”. This
change in the legal status of clinical negligence claims
further heightens the need for research to define optimal
surveillance after EVAR.
It has been hypothesised that the risk of reintervention
after EVAR is not homogeneous,16 and it is of interest to
consider proposals for surveillance in light of this.
Increasing the proportional use of duplex USS after EVAR
has been advocated to reduce surveillance-related
morbidity9 and this may be a safe strategy in low-risk
patients, whilst offering reasonable accuracy compared to
CT for endoleak detection.10e12 Plain abdominal radio-
graphs may depict stent-graft migration and component
separation, offering a useful adjunct to duplex ultrasound
surveillance. Oblique imaging can improve detection of
wire fractures. Radiographs are, however, notoriously
difficult to interpret with respect to lesser degrees of
migration.29 The challenge of exact reproducibility, so as to
avoid parallax assessment, limits reliance upon plain
radiographs.
The incidence of late endograft rupture demonstrated in
the long-term results of the EVAR-1 trial highlight the need
for more effective surveillance of high-risk patients.4 A
formal analysis of data from EVAR-1 and EVAR-2 demon-
strated that the presence of a complication requiring
reintervention (type I or III endoleak, type II endoleak with
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predictor of post-EVAR rupture and the authors have high-
lighted the need for a low threshold towards reintervention
to obtain a definitive solution for these patients (Hazard
ratio 8.83).26
These long-term EVAR trial data support the hypothesis
that the risk of reintervention after EVAR is not homoge-
neous and that there remains a high-risk subgroup, for
which more intensive surveillance may be required than is
provided by generic surveillance. In order to define these
subgroups, study of the underlying determinants of rein-
tervention after EVAR is required. Post-EVAR sac enlarge-
ment has been shown to correlate with hostile AAA neck
diameter and angulation in addition to hostile common iliac
artery diameter where these aspects of morphology were
not compliant with the manufacturer’s IFU.30 It has been
hypothesised that adverse aneurysm morphology may
increase the risk of reintervention after EVAR, and further
study of the relationship between reintervention and
aneurysm morphology is required.16
This might allow consensus in risk-stratified surveillance,
in which the intensity of rationalised surveillance could be
stratified in proportion to reintervention risk to obtain the
greatest clinical and economic efficacy. The incidence of
peri-operative rupture following the omission of pre-
discharge imaging in long-term data from the EVAR-1 and
EVAR-2 trials has highlighted the need for quality control at
the point of discharge. It is therefore of concern that 10/41
centres in the present study relied on 1-view angiography in
the absence of CT or duplex imaging to ensure the absence
of complications requiring reintervention.26
Current differences in surveillance intensity and
modality could in theory lead to national differences in cost
effectiveness, patient satisfaction, the development of
renal dysfunction and overall outcomes after EVAR. The
NIHR Health Technology Assessment of EVAR reported that
surveillance accounted for 65% of the excess cost of EVAR
compared to open repair, and that investigating optimal
surveillance after EVAR should be a research priority.31 The
results of the present study confirmed that surveillance
after EVAR remains controversial, and represents an area of
significant variation in national practice. Further research
is urgently required to define a rationalised, clinically
effective and cost-effective protocol for EVAR surveillance,
which should be subject to a clinical trial following proof of
its safety and efficacy.
Conclusion
The results of this survey demonstrated significant hetero-
geneity in national practice for surveillance after EVAR, in
terms of the intensity and duration of surveillance as well
as the type of imaging modalities that were employed. The
relationship between surveillance and reintervention after
EVAR remains poorly understood. Efforts should be made to
establish consensus towards a national surveillance
protocol that is clinically and economically effective.
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